BCAL Diagnostics (ASX:BDX) Operating Margin %: -11,672.09% (As of Dec. 2025)


What is BCAL Diagnostics Operating Margin %?

BCAL Diagnostics ASX:BDX +10.96% Operating Margin % is -11,672.09% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, BCAL Diagnostics ranks worse than 98.53% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. BCAL Diagnostics's Operating Income for the six months ended in Dec. 2025 was A$-5.02 Mil. BCAL Diagnostics's Revenue for the six months ended in Dec. 2025 was A$0.04 Mil. Therefore, BCAL Diagnostics's Operating Margin % for the quarter that ended in Dec. 2025 was -11,672.09%.

The historical rank and industry rank for BCAL Diagnostics's Operating Margin % or its related term are showing as below:

ASX:BDX' s Operating Margin % Range Over the Past 10 Years
Min: -45281.82   Med: -45281.82   Max: -22432.56
Current: -22432.56


ASX:BDX's Operating Margin % is ranked worse than
98.53% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.195 vs ASX:BDX: -22432.56

BCAL Diagnostics's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

BCAL Diagnostics's Operating Income for the six months ended in Dec. 2025 was A$-5.02 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was A$-9.65 Mil.

Warning Sign:

BCAL Diagnostics Ltd has never been profitable in the past 3 years. It lost money every year.


BCAL Diagnostics  (ASX:BDX) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


BCAL Diagnostics Operating Margin % Related Terms


BCAL Diagnostics Operating Margin % Historical Data

* Premium members only.

The historical data trend for BCAL Diagnostics's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BCAL Diagnostics Operating Margin % Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Operating Margin %
0.00 0.00 0.00 -45,281.82

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -11,672.09

ASX:BDX vs TMO, DHR, IDXX: Operating Margin % Comparison

For the Diagnostics & Research subindustry, BCAL Diagnostics's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BCAL Diagnostics Operating Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BCAL Diagnostics's Operating Margin % distribution charts can be found below:

* The bar in red indicates where BCAL Diagnostics's Operating Margin % falls into.



BCAL Diagnostics Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

BCAL Diagnostics's Operating Margin % for the fiscal year that ended in Jun. 2025 is calculated as

Operating Margin %=Operating Income (A: Jun. 2025 ) / Revenue (A: Jun. 2025 )
=-9.962 / 0.022
=-45,281.82 %

BCAL Diagnostics's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-5.019 / 0.043
=-11,672.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -11,672.09% mean?
BCAL Diagnostics (ASX:BDX) has a Operating Margin % of -11,672.09% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on BCAL Diagnostics and its competitors. According to the industry distribution chart, BCAL Diagnostics ranks #201 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 98.5%.
Is BCAL Diagnostics' Operating Margin % too high?
BCAL Diagnostics' current Operating Margin % is -11,672.09%. Based on the distribution chart, BCAL Diagnostics ranks #201 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does BCAL Diagnostics' Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, BCAL Diagnostics ranks #201 out of 204 companies for Operating Margin %. This places BCAL Diagnostics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on BCAL Diagnostics and its competitors. BCAL Diagnostics's current Operating Margin % is -11,672.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BCAL Diagnostics stock overvalued right now?
BCAL Diagnostics (ASX:BDX) has a current Operating Margin % of -11,672.09%. The current Operating Margin % is -11,672.09%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For BCAL Diagnostics (ASX:BDX), the current Operating Margin % is -11,672.09% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BCAL Diagnostics Business Description

Address 50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer that is safe, cost-effective, accurate, and available to all women regardless of age, race, and geographic location.